- Home
- FMY vs MIRA Comparison
FMY vs MIRA Comparison
Compare FMY & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMY | MIRA |
|---|---|---|
| Founded | 2005 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.7M | 53.2M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FMY | MIRA |
|---|---|---|
| Price | $11.73 | $1.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.2K | ★ 121.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 6.98% | N/A |
| EPS Growth | N/A | ★ 20.31 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.65 | $0.81 |
| 52 Week High | $12.39 | $2.45 |
Technical Indicators
Market Signals| Indicator | FMY | MIRA |
|---|---|---|
| Relative Strength Index (RSI) | 33.42 | 42.41 |
| Support Level | N/A | $1.13 |
| Resistance Level | $12.34 | $1.35 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 1.54 | 36.17 |
Price Performance
Historical ComparisonAbout FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.